Table 1

Characteristics of dialysis patients with diabetes

TotalHypoglycemic agent usersHypoglycemic agent non-usersP value
n40 41727 76112 656
Mean (SD)Missing (%)Mean (SD)Mean (SD)
Age (years)67.3±11.2066.8±11.268.4±11.3<0.001
Sex, female (%)30.8032.028.2<0.001
Body mass index (kg/m2)22.3±4.1522.4±4.122.0±3.9<0.001
Primary kidney disease, DKD (%)86.7088.682.5<0.001
Albumin (g/dL)3.6±0.403.6±0.43.6±0.4<0.001
Hemoglobin (g/L)107±120107±12107±120.001
Hemoglobin A1c (%)6.2±1.1496.4±1.25.7±0.9<0.001
Glycated albumin (%)21.3±5.3022.3±5.519.3±4.4<0.001
C-reactive protein (mg/dL)0.15 (0.06, 0.46)130.15 (0.06, 0.47)0.14 (0.06, 0.46)0.99
Geriatric nutritional risk index92.8±8.0593.0±7.792.4±8.4<0.001
Systolic blood pressure (mm Hg)157±241157±24156±24<0.001
Diastolic blood pressure (mm Hg)78±14178±1478±150.95
Antihypertensive drug use (%)74.8475.972.3<0.001
Calcium (mg/dL)8.7±0.708.7±0.78.7±0.8<0.001
Phosphate (mg/dL)5.2±1.405.2±1.45.2±1.50.40
Intact parathyroid hormone (mg/dL)128 (70, 207)4127 (69, 205)131 (73, 211)<0.001
Insulin use (%)36.3153.30<0.001
 DPP4 inhibitor use (%)32.0347.10<0.001
 Other hypoglycemic agent use (%)23.0334.00<0.001
Smoking (%)14.91215.014.60.24
Hemodiafiltration (%)10.0010.49.1<0.001
Kt/V1.39±0.2841.39±0.281.38±0.280.006
Comorbid condition (%)37.7638.037.10.09
Malnutrition (%)20.6019.722.5<0.001
  • Hypoglycemic agents included insulin, dipeptidyl peptidase-4 inhibitor (DPP4i), and oral hypoglycemic agents (OHA). The Global Leadership Initiative on Malnutrition (GLIM) criteria (serum albumin <3.8 g/dL, and patients whose body mass index was low (<18.5 if <70 years old and <20 if ≥70 years old) or who experienced weight loss more than 10% during 2013–2014) were used to assess malnutrition.12

  • DKD, diabetic kidney disease; DPP4, dipeptidyl peptidase-4.